Clinical characteristics and underlying disease distribution among Japanese patients with optic neuritis

Purpose To investigate the distribution of underlying diseases in optic neuritis and related clinical characteristics, treatment strategies, and relapse patterns in Japanese patients using strict radiological diagnostic criteria and pretreatment antibody testing. Study design Retrospective cohort study Methods We retrospectively reviewed the charts of 112 patients with first-onset optic neuritis who visited Tohoku University Hospital between March 2016 and November 2025. Diagnoses of optic neuritis were based on visual dysfunction and contrast-enhanced orbital magnetic resonance imaging. Serum anti-myelin oligodendrocyte glycoprotein (MOG) antibodies and anti-aquaporin-4 antibodies were measured using live-cell-based assays before initiation of acute-phase treatment. Patients were classified into groups according to the following underlying diseases: MOG-associated disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and idiopathic optic neuritis. Clinical characteristics, treatment strategies, relapse rates, and cumulative relapse rates were analyzed retrospectively. Results The distribution of underlying diseases was 36.6% MOGAD, 33.0% idiopathic, 21.4% NMOSD, and 8.9% MS. MOGAD patients were characterized by a younger onset, bilateral involvement, and more frequent optic disc swelling, whereas NMOSD patients were predominantly women, older at onset, and had unilateral involvement. Among the 90 patients followed for more than 12 months, the overall relapse rate was 17.8%, with the highest relapse rate observed for NMOSD (25.0%). Kaplan–Meier analysis demonstrated gradually decreasing cumulative relapse-free rates, particularly in NMOSD and idiopathic optic neuritis. The 36-month cumulative relapse-free rates were 81.6% in MOGAD, 87.5% in MS, 72.9% in NMOSD, and 61.3% in idiopathic optic neuritis. No significant difference in relapse-free rates was observed among underlying diseases (log-rank test, p = 0.84). Conclusions MOGAD and NMOSD accounted for a relatively large proportion of optic neuritis cases in study population. Antibody-associated optic neuritis was observed across a wide age range, suggesting the importance of antibody testing regardless of age. Early diagnosis and multidisciplinary therapeutic intervention may contribute to improved long-term outcomes.

Authors

Institutions

Publication Details

Journal
Japanese Journal of Ophthalmology
Published
2026-11-19
DOI
https://doi.org/10.1007/s10384-026-01454-w
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical characteristics and underlying disease distribution among Japanese patients with optic neuritis

Tatsuro Misu, Noriko Himori, Toru Nakazawa, Shuhei Nishiyama et al.
Japanese Journal of Ophthalmology
Multiple Sclerosis Research Studies
article

Clinical characteristics and underlying disease distribution among Japanese patients with optic neuritis

Tatsuro Misu, Noriko Himori, Toru Nakazawa, Shuhei Nishiyama, Kimihiko Kaneko, Masashi Aoki
article en

Abstract

Purpose To investigate the distribution of underlying diseases in optic neuritis and related clinical characteristics, treatment strategies, and relapse patterns in Japanese patients using strict radiological diagnostic criteria and pretreatment antibody testing. Study design Retrospective cohort study Methods We retrospectively reviewed the charts of 112 patients with first-onset optic neuritis who visited Tohoku University Hospital between March 2016 and November 2025. Diagnoses of optic neuritis were based on visual dysfunction and contrast-enhanced orbital magnetic resonance imaging. Serum anti-myelin oligodendrocyte glycoprotein (MOG) antibodies and anti-aquaporin-4 antibodies were measured using live-cell-based assays before initiation of acute-phase treatment. Patients were classified into groups according to the following underlying diseases: MOG-associated disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and idiopathic optic neuritis. Clinical characteristics, treatment strategies, relapse rates, and cumulative relapse rates were analyzed retrospectively. Results The distribution of underlying diseases was 36.6% MOGAD, 33.0% idiopathic, 21.4% NMOSD, and 8.9% MS. MOGAD patients were characterized by a younger onset, bilateral involvement, and more frequent optic disc swelling, whereas NMOSD patients were predominantly women, older at onset, and had unilateral involvement. Among the 90 patients followed for more than 12 months, the overall relapse rate was 17.8%, with the highest relapse rate observed for NMOSD (25.0%). Kaplan–Meier analysis demonstrated gradually decreasing cumulative relapse-free rates, particularly in NMOSD and idiopathic optic neuritis. The 36-month cumulative relapse-free rates were 81.6% in MOGAD, 87.5% in MS, 72.9% in NMOSD, and 61.3% in idiopathic optic neuritis. No significant difference in relapse-free rates was observed among underlying diseases (log-rank test, p = 0.84). Conclusions MOGAD and NMOSD accounted for a relatively large proportion of optic neuritis cases in study population. Antibody-associated optic neuritis was observed across a wide age range, suggesting the importance of antibody testing regardless of age. Early diagnosis and multidisciplinary therapeutic intervention may contribute to improved long-term outcomes.

Japanese Journal of Ophthalmology
Tohoku University (JP)
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon